Evidence map›Paper›PMID 27350955›Full record

ReviewEye and vision (London, England)2016

Genetics in Keratoconus: where are we?

Yelena Bykhovskaya, Benjamin Margines, Yaron S Rabinowitz

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Eye and vision (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03071302 (Evaluation of Tomographic and Genetic Aspects of Keratoconus Patients Compared to Sounds Corneas), which is not on this map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03071302 nacompletednot on this map

Evaluation of Tomographic and Genetic Aspects of Keratoconus Patients Compared to Sounds Corneas

TypeinterventionalSponsorSao Jose do Rio Preto Medical SchoolRan2015 to 2016Enrolled210ConditionsKeratoconus, Keratoconus, Unspecified, BilateralArmsEVALUATION OF VSX1, SOD1, and TIMP3 genes
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Update on the Physiopathology of Keratoconus.Medical sciences (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Variants in theHeliyon · 2024
    Article
  16. Article
  17. Systemic and Ocular Associations of Keratoconus.Expert review of ophthalmology · 2024
    Article
  18. Animal Models in Eye Research: Focus on Corneal Pathologies.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yelena BykhovskayaRegenerative Medicine Institute and Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, USA ; Cornea Genetic Eye Institute, 50 N. La Cienega Blvd. Suite #340, Beverly Hills, CA 90211 USA.
Benjamin MarginesCornea Genetic Eye Institute, 50 N. La Cienega Blvd. Suite #340, Beverly Hills, CA 90211 USA.
Yaron S RabinowitzRegenerative Medicine Institute and Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, USA ; Cornea Genetic Eye Institute, 50 N. La Cienega Blvd. Suite #340, Beverly Hills, CA 90211 USA ; The Jules Stein Eye Institute, University of California Los Angeles, Los Angeles, USA.
Cornea Eye Institute · USCedars-Sinai Medical Center · US

Funding

GENETIC FACTORS IN KERATOCONUSR01EY009052 · NEI · CEDARS-SINAI MEDICAL CENTER · PI RABINOWITZ, YARON SOLOMON, ROTTER, JEROME I · 1993 to 2019
$10.9M
NEI NIH HHS R01 EY009052
6 · The paper itself

Abstract

Keratoconus (KC) is a non-inflammatory thinning and protrusion of the cornea in which the cornea assumes a conical shape. Complex etiology of this condition at present remains an enigma. Although environmental factors have been involved in KC pathogenesis, strong underlining genetic susceptibility has been proven. The lack of consistent findings among early genetic studies suggested a heterogeneity and complex nature of the genetic contribution to the development of KC. Recently, genome-wide linkage studies (GWLS) and genome-wide association studies (GWAS) were undertaken. Next-generation sequencing (NGS)-based genomic screens are also currently being carried out. Application of these recently developed comprehensive genetic tools led to a much greater success and increased reproducibility of genetic findings in KC. Involvement of the LOX gene identified through GWLS has been confirmed in multiple cohorts of KC patients around the world. KC susceptibility region located at the 2q21.3 chromosomal region near the RAB3GAP1 gene identified through GWAS was independently replicated. Rare variants in the ZNF469 gene (mutated in corneal dystrophy Brittle Cornea Syndrome) and in the TGFBI gene (mutated in multiple corneal epithelial-stromal TGFBI dystrophies) have been repeatedly identified in familial and sporadic KC patients of different ethnicities. Additional comprehensive strategies using quantitative endophenotypes have been successfully employed to bring further understanding to the genetics of KC. Additional genetic determinants including the COL5A1 gene have been identified in the GWAS of KC-related trait central corneal thickness. These recent discoveries confirmed the importance of the endophenotype approach for studying complex genetic diseases such as KC and showed that different connective tissue disorders may have the same genetic determinants.

Indexed as

Complex diseaseCorneal dystrophyGenetic associationGeneticsGenetic variationGenotypingKeratoconusLinkageSequencing

Identifiers

PMID27350955
PMCPMC4922054
OpenAlexW2471421527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.